What are Elaprase sales (revenue) in the US?
Elaprase (idursulfase) is marketed in the US, but the exact “US sales” figure depends on the specific reporting source (for example, a company’s annual report, quarterly sales disclosure, or a market-data provider). The information you provided is too limited to extract a reliable US sales number.
Where do Elaprase US sales numbers usually come from?
US sales for branded drugs like Elaprase are commonly reported through:
- Public filings from the manufacturer or partner (annual reports/quarterly earnings releases).
- Prescription/therapeutic sales datasets sold by market research firms.
- Government or payer datasets (less common for a single brand’s “sales” headline figure).
If you meant “Elaprase sales by year in the US,” what should you specify?
To give an accurate number, I need at least one detail:
- Which years (e.g., 2022, 2023, 2024)?
- Do you mean “US revenue” (net sales), “US prescriptions,” or “units sold”?
- Which source do you want (company filings vs market research)?
Is there a quick reason Elaprase sales might be changing in the US?
Elaprase sales can shift based on:
- Diagnosed patient numbers and treatment adoption in MPS II (Hunter syndrome).
- Competition from other therapies.
- Pricing changes and payer contracting.
If you share the exact text you have (or the source you’re looking at) or confirm the year and what “sales” means (net sales vs units vs prescriptions), I can produce a precise US sales answer.